Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity. - Lu DR; Osgood T; Ma S; Zhang H; Kanke M; Tan JA; Paudel SN; Zhou H; Estrada J; Yamawaki T; Tarbell K; Rex K; et al. (Cancer immunology research, 2026)